• Endothelium Function in AS Improved with Methotrexate Alone or Combined with Anti-TNF Agents, Study Finds
  • EU Approves Cimzia for Pregnant and Breastfeeding Women with a Rheumatic Disease
  • A Solid Foundation and Community Will Keep You Standing
  • Novartis Initiates Phase 3 Trial in AS Comparing Cosentyx to Adalimumab Biosimilar
  • The New Year and the Journey Ahead
  • Pain in AS May Be Caused by Sources Other Than Spine Inflammation, Opioid Study Suggests
  • Low-dose CT Can Improve Assessment of Ankylosing Spondylitis Progression, Study Suggests
  • UCB’s Bimekizumab Shows Promising Results in AS Clinical Trial
  • FDA Approves Ixifi, a Remicade Biosimilar, for Ankylosing Spondylitis, Other Indications
  • Axial Spondyloarthritis Patients Who Stop Smoking Lower Disease Activity, Feel Better
  • Study Launched to Assess Impact of Higher Dose of Cosentyx in Patients with AS
  • Nearly a Fifth of IBD Patients Have a Joint Condition, Veterans Study in Texas Indicates